237 related articles for article (PubMed ID: 19595713)
21. Novel roles of Akt and mTOR in suppressing TGF-beta/ALK5-mediated Smad3 activation.
Song K; Wang H; Krebs TL; Danielpour D
EMBO J; 2006 Jan; 25(1):58-69. PubMed ID: 16362038
[TBL] [Abstract][Full Text] [Related]
22. Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidylinositol 3-kinase pathway.
Sulpice E; Bryckaert M; Lacour J; Contreres JO; Tobelem G
Blood; 2002 Nov; 100(9):3087-94. PubMed ID: 12384403
[TBL] [Abstract][Full Text] [Related]
23. Activation of a serine/threonine kinase signaling pathway by transforming growth factor type beta.
Atfi A; Lepage K; Allard P; Chapdelaine A; Chevalier S
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12110-4. PubMed ID: 8618854
[TBL] [Abstract][Full Text] [Related]
24. The kinase activity of the Ser/Thr kinase BUB1 promotes TGF-β signaling.
Nyati S; Schinske-Sebolt K; Pitchiaya S; Chekhovskiy K; Chator A; Chaudhry N; Dosch J; Van Dort ME; Varambally S; Kumar-Sinha C; Nyati MK; Ray D; Walter NG; Yu H; Ross BD; Rehemtulla A
Sci Signal; 2015 Jan; 8(358):ra1. PubMed ID: 25564677
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of FXYD3 is induced by transforming growth factor-β signaling via ZEB1/δEF1 in human mammary epithelial cells.
Yamamoto H; Mukaisho K; Sugihara H; Hattori T; Asano S
Biol Pharm Bull; 2011; 34(3):324-9. PubMed ID: 21372379
[TBL] [Abstract][Full Text] [Related]
26. Characterization of growth factor-induced serine phosphorylation of tumor necrosis factor-alpha converting enzyme and of an alternatively translated polypeptide.
Fan H; Turck CW; Derynck R
J Biol Chem; 2003 May; 278(20):18617-27. PubMed ID: 12621058
[TBL] [Abstract][Full Text] [Related]
27. Differential intracellular signalling induced by TGF-beta in rat adult hepatocytes and hepatoma cells: implications in liver carcinogenesis.
Caja L; Ortiz C; Bertran E; Murillo MM; Miró-Obradors MJ; Palacios E; Fabregat I
Cell Signal; 2007 Apr; 19(4):683-94. PubMed ID: 17055226
[TBL] [Abstract][Full Text] [Related]
28. Caveolin-1 is required for TGF-β-induced transactivation of the EGF receptor pathway in hepatocytes through the activation of the metalloprotease TACE/ADAM17.
Moreno-Càceres J; Caja L; Mainez J; Mayoral R; Martín-Sanz P; Moreno-Vicente R; Del Pozo MÁ; Dooley S; Egea G; Fabregat I
Cell Death Dis; 2014 Jul; 5(7):e1326. PubMed ID: 25032849
[TBL] [Abstract][Full Text] [Related]
29. TGF-beta receptor levels regulate the specificity of signaling pathway activation and biological effects of TGF-beta.
Rojas A; Padidam M; Cress D; Grady WM
Biochim Biophys Acta; 2009 Jul; 1793(7):1165-73. PubMed ID: 19339207
[TBL] [Abstract][Full Text] [Related]
30. TrkC binds to the type II TGF-beta receptor to suppress TGF-beta signaling.
Jin W; Yun C; Kwak MK; Kim TA; Kim SJ
Oncogene; 2007 Dec; 26(55):7684-91. PubMed ID: 17546043
[TBL] [Abstract][Full Text] [Related]
31. Transforming growth factor-beta type I receptor/ALK5 contributes to doxazosin-induced apoptosis in H9C2 cells.
Yang YF; Wu CC; Chen WP; Su MJ
Naunyn Schmiedebergs Arch Pharmacol; 2009 Dec; 380(6):561-7. PubMed ID: 19727674
[TBL] [Abstract][Full Text] [Related]
32. Caveolin-2 is a negative regulator of anti-proliferative function and signaling of transforming growth factor-β in endothelial cells.
Xie L; Vo-Ransdell C; Abel B; Willoughby C; Jang S; Sowa G
Am J Physiol Cell Physiol; 2011 Nov; 301(5):C1161-74. PubMed ID: 21832243
[TBL] [Abstract][Full Text] [Related]
33. TGF-β-induced expression of IGFBP-3 regulates IGF1R signaling in human osteosarcoma cells.
Schedlich LJ; Yenson VM; Baxter RC
Mol Cell Endocrinol; 2013 Sep; 377(1-2):56-64. PubMed ID: 23831640
[TBL] [Abstract][Full Text] [Related]
34. PICK1 promotes caveolin-dependent degradation of TGF-β type I receptor.
Zhao B; Wang Q; Du J; Luo S; Xia J; Chen YG
Cell Res; 2012 Oct; 22(10):1467-78. PubMed ID: 22710801
[TBL] [Abstract][Full Text] [Related]
35. The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner.
Sorrentino A; Thakur N; Grimsby S; Marcusson A; von Bulow V; Schuster N; Zhang S; Heldin CH; Landström M
Nat Cell Biol; 2008 Oct; 10(10):1199-207. PubMed ID: 18758450
[TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor-beta stimulates intestinal epithelial focal adhesion kinase synthesis via Smad- and p38-dependent mechanisms.
Walsh MF; Ampasala DR; Hatfield J; Vander Heide R; Suer S; Rishi AK; Basson MD
Am J Pathol; 2008 Aug; 173(2):385-99. PubMed ID: 18583311
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effect of a TGFbeta receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells.
Shinto O; Yashiro M; Kawajiri H; Shimizu K; Shimizu T; Miwa A; Hirakawa K
Br J Cancer; 2010 Mar; 102(5):844-51. PubMed ID: 20145621
[TBL] [Abstract][Full Text] [Related]
38. CHIP controls the sensitivity of transforming growth factor-beta signaling by modulating the basal level of Smad3 through ubiquitin-mediated degradation.
Xin H; Xu X; Li L; Ning H; Rong Y; Shang Y; Wang Y; Fu XY; Chang Z
J Biol Chem; 2005 May; 280(21):20842-50. PubMed ID: 15781469
[TBL] [Abstract][Full Text] [Related]
39. Involvement of EGF receptor and c-Src in the survival signals induced by TGF-beta1 in hepatocytes.
Murillo MM; del Castillo G; Sánchez A; Fernández M; Fabregat I
Oncogene; 2005 Jun; 24(28):4580-7. PubMed ID: 15856020
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of transforming growth factor β1 in malignant prostate cells is partly caused by a runaway of TGF-β1 auto-induction mediated through a defective recruitment of protein phosphatase 2A by TGF-β type I receptor.
Yu N; Kozlowski JM; Park II; Chen L; Zhang Q; Xu D; Doll JA; Crawford SE; Brendler CB; Lee C
Urology; 2010 Dec; 76(6):1519.e8-13. PubMed ID: 21030067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]